The largest database of trusted experimental protocols

4 protocols using rpa32 ps4 8

1

DNA Damage Response Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in this study: PRP19 (ab27692, 1:400 IF, 1:1000 WB), ATM pS1981 (ab81292, 1:1000 WB), DNAPKcs pS2056 (ab18192, 1:1000 WB) and RPA32 pT21 (ab109394, 1:5000 WB) antibodies were from Abcam, CHK1 (SC-8404, 1:1000 WB), Myc (SC-40, 1:1000 WB) and HA (SC-7392, 1:1000 WB) antibodies were from Santa Cruz; RPA32 antibodies (MA1–26418, 1:500 IF, 1:1000 WB) were from Thermo, ATM (A300–299A, 1:1000 WB), RPA32 pS4/8 (A300–245A, 1:1000 WB), RPA32 pS33 (A300–246A, 1:5000 WB), RFWD3 (A301–397A, 1:250 IF, 1:1000 WB) antibodies were from Bethyl; ubiquitin antibodies were from Covance (MMS-257P, 1:1000 WB); CDC5L antibodies were from BD-Bioscience (612362, 1:1000 WB); anti-FLAG antibodies were from Sigma (F1804, 1:800 IF, 1:1000 WB); CHK1 pS345 (2348, 1:1000 WB), GAPDH (5174, 1:1000 WB), DNAPKcs (12311, 1:1000 WB) and tubulin (2144, 1:1000 WB) antibodies were from Cell Signaling.
+ Open protocol
+ Expand
2

Investigating Cell Cycle Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemical inhibitors were used at the indicated concentrations unless stated otherwise: WEE1 inhibitor MK-1775 (500 nM; Selleck Chemicals), CHK1 inhibitor SB 218078 (2 μM; Tocris), ATR inhibitor VE-821 (20 μM; Selleck Chemicals), CDK1 inhibitor RO-3306 (10 μM; Calbiochem), CDK inhibitor Roscovitine (20 μM; Selleck Chemicals), thymidine (2 mmol/L; Sigma-Aldrich), and nocodazole (100 ng/mL; Sigma-Aldrich), IdU (10 μg/ml, Sigma-Aldrich), CIdU (10 μg/ml, Sigma-Aldrich). The following antibodies were used: CHK1 (Santa Cruz Biotechnology), CHK1-pS345 (Cell Signaling), CHK2 (Santa Cruz Biotechnology), CHK2-pT68 (Cell Signaling), phospho-Histone-H2AX-Ser139 (γH2AX; Millpore), CDK1 (Santa Cruz Biotechnology), CDK1-pTyr15 (Cell Signaling), RPA70 (Abcam), phospho-(Ser) CDKs Substrate (pCDK Substrate; Cell Signaling), CDK2 (Santa Cruz Biotechnology), CDK2-pTyr15 (Abcam), RPA32-pT21 (Abcam), RPA32-pS33 (Abcam), RPA32-pS4/8 (Bethyl Laboratories), RPA32 (Bethyl Laboratories), WEE1 (Santa Cruz Biotechnology), α-Tubulin (Sigma-Aldrich), CIdU (rat anti-BrdU; Accurate Chemical), IdU (mouse anti-BrdU; Becton Dickinson).
+ Open protocol
+ Expand
3

Antibody Profiling for Cell Cycle Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercially available antibodies obtained from Cell Signaling against the indicated proteins were: Cdc2/CDK1 (Cat # 9112S), CDK1-P-Y15 (Cat # 4539S), Histone H3-P-S28 (Cat # 9713S), p53-P-S15 (Cat # 9284), SMC1-P-957 (Cat # 4805S), SMC1 (Cat # 4802S), CDC25A (Cat # 3652S) and Chk2-P-T68 (Cat # 2661S). Antibodies obtained from Santa Cruz Biotechnology were CDC25A F-6 (Cat # sc -7389), CDC25C H-150 (Cat # sc-5620), Cdc2 (Cat # sc-54). Others were against actin (Cat. 109 # MA515739, Pierce), RPA32-P-S4/8 (Cat # A300-245A, Bethyl), cyclin A (Cat # 06-138, Upstate) γH2AX (Cat # 05-636, Millipore), Chk2 Clone 7 (Cat # 05-649, Millipore), cyclin B1 (Cat. # 05-373, Millipore), and CDK1 (Cat. #Ab18, Abcam). Secondary antibodies have previously been described. Additional antibodies used for immunofluorescence include: cyclin B1 (Cat # 4138S, Cell signaling), Alexa 488 (anti-mouse Cat # A11029, anti-rabbit Cat # A11034, Invitrogen) and Alexa 568 (anti-mouse Cat # A11031, anti-rabbit Cat # A11036, Invitrogen). NS1 CE10 and NS1 91W were described previously [7] (link).
+ Open protocol
+ Expand
4

Isolation and Maintenance of Mouse Embryonic Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
MEF cells were isolated from embryonic day 13.5 (E13.5) embryos as described previously (Castillo et al. 2014 (link)). Primary MEFs were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin antibiotics and maintained in 3% O2/5% CO2 in an incubator at 37°C. Immortalized MEFs were generated by spontaneous immortalization following the 3T3 protocol as described previously (Castillo et al. 2014 (link)). PD20 and PD20/FANCD2 cells were maintained in RPMI1640 medium with 15% FBS. U2OS cells were grown in McCoy's 5A medium with 10% FBS. CAPAN-1 cells were cultured in Iscove's modified Dulbecco's medium (IMDM) (Hyclone, Thermo Scientific) with 20% FBS. Antibodies used in this study included Abro1 (Hu et al. 2011 (link)), BRCC36 (Abcam), BRE (Hu et al. 2011 (link)), NBA1 (Hu et al. 2011 (link)), 53BP1 (Novus Biologicals), BLM (Bethyl Laboratories), BrdU (BD Bioscience), RAD51 (Calbiochem), RPA32pS4/8 (Bethyl Laboratories), p-CHK1 (Cell Signaling), CHK1 (Santa Cruz Biotechnolgoy), γH2AX (Ser139; Upstate Biotechnology), Flag (Sigma), BRCA2 (Abcam, ab27976), γ-tubulin (Sigma), DNA2 (Proteintech, 18727-1-AP), FANCD2 (Santa Cruz Biotechnology, sc-20022), and H3 (Abcam). Chemicals used in this study included BrdU (Sigma), APH (Sigma), HU (Sigma), MMC (Sigma), and camptothecin (CPT) (Sigma).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!